meglumine has been researched along with Chronic Kidney Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davenport, MS; Gagnier, JJ; MacEachern, MP; Shankar, PR; Singer, L; Woolen, SA | 1 |
| Kalb, B; Martin, DR; Mittal, A; Mittal, PK; Salman, K; Vedantham, S | 1 |
| Akoum, N; Barakat, M; Burgon, N; Kholmovski, E; Koopmann, M; Mahnkopf, C; Marrouche, N; Navaravong, L; Ranjan, R | 1 |
| America, YG; Braam, B; Cramer, MJ; de Vries, JJ; Doevendans, PA; Emans, ME; Gaillard, CA; Hillege, HL; Meiss, L; van der Putten, K; Velthuis, BK | 1 |
| Bakris, GL; Flynn, C | 1 |
2 review(s) available for meglumine and Chronic Kidney Diseases
| Article | Year |
|---|---|
Risk of Nephrogenic Systemic Fibrosis in Patients With Stage 4 or 5 Chronic Kidney Disease Receiving a Group II Gadolinium-Based Contrast Agent: A Systematic Review and Meta-analysis.
Topics: Contraindications, Drug; Contrast Media; Gadolinium; Glomerular Filtration Rate; Heterocyclic Compounds; Humans; Meglumine; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Practice Guidelines as Topic; Renal Insufficiency, Chronic; Risk; Severity of Illness Index; United States; United States Food and Drug Administration | 2020 |
Noninsulin glucose-lowering agents for the treatment of patients on dialysis.
Topics: Adamantane; Biguanides; Diabetic Nephropathies; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Disease Progression; Glucagon-Like Peptides; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Linagliptin; Meglumine; Metformin; Nitriles; Piperidines; Purines; Pyrazines; Pyrrolidines; Quinazolines; Renal Dialysis; Renal Insufficiency, Chronic; Sitagliptin Phosphate; Sulfonylurea Compounds; Thiazolidinediones; Treatment Outcome; Triazoles; Uracil; Vildagliptin | 2013 |
1 trial(s) available for meglumine and Chronic Kidney Diseases
| Article | Year |
|---|---|
Atherosclerotic renal artery stenosis is prevalent in cardiorenal patients but not associated with left ventricular function and myocardial fibrosis as assessed by cardiac magnetic resonance imaging.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Atherosclerosis; Cardio-Renal Syndrome; Chi-Square Distribution; Contrast Media; Erythropoietin; Female; Fibrosis; Glomerular Filtration Rate; Heart Failure; Hematinics; Humans; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Myocardium; Netherlands; Organometallic Compounds; Predictive Value of Tests; Prevalence; Prognosis; Renal Artery; Renal Artery Obstruction; Renal Insufficiency, Chronic; Risk Assessment; Risk Factors; Severity of Illness Index; Stroke Volume; Ventricular Function, Left | 2012 |
2 other study(ies) available for meglumine and Chronic Kidney Diseases
| Article | Year |
|---|---|
Notice of Withdrawal: No Incidence of Nephrogenic Systemic Fibrosis after Gadobenate Dimeglumine Administration in Patients Undergoing Dialysis or Those with Severe Chronic Kidney Disease.
Topics: Adolescent; Adult; Aged; Contrast Media; Female; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Renal Dialysis; Renal Insufficiency, Chronic; Retrospective Studies; Young Adult | 2018 |
Improvement in estimated glomerular filtration rate in patients with chronic kidney disease undergoing catheter ablation for atrial fibrillation.
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Biomarkers; Catheter Ablation; Contrast Media; Creatinine; Databases, Factual; Female; Fibrosis; Glomerular Filtration Rate; Heart Atria; Humans; Kidney; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Predictive Value of Tests; Recovery of Function; Recurrence; Renal Insufficiency, Chronic; Risk Factors; Time Factors; Treatment Outcome; Utah | 2015 |